Ascendis Pharma A ASND
NASDAQ ASND
$227.83 -0.24 (-0.11%)
At close: Sep 30, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Long-Term Deferred Tax (2023 - 2026)

Updated

Ascendis Pharma A (ASND) recorded Long-Term Deferred Tax of $812.81 million in the quarter ended Jun 30, 2026, up 0.6% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Long-Term Deferred Tax (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Ascendis Pharma A reported Long-Term Deferred Tax of -$10.87 million.

  • Across earlier years, Long-Term Deferred Tax came in at -$7.86 million in the year ended Dec 31, 2024 and -$6.31 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ascendis Pharma A 14.12 Bn 10.37 Bn 362.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 812.81 Mn
Mar 31, 2026 808.29 Mn
Dec 31, 2025 -11.20 Mn
Dec 31, 2024 -7.76 Mn
Dec 31, 2023 -6.27 Mn
API Access

Ascendis Pharma A Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=ASND&period=max&api_key=YOUR_API_KEY